• 1. Excitonic channels from bio-inspired templated supramolecular assembly of J-aggregate nanowires?
  Daniel Messmer,Stefan Salentinig,Jakob Heier Nanoscale, 2019,11, 6929-6938
• 2. Fe3O4 nanoparticle chains with N-doped carbon coating: magnetotactic bacteria assisted synthesis and high-rate lithium storage?
  Dan Yang,Yanping Zhou,Xianhong Rui,Jixin Zhu,Ziyang Lu,Eileen Fong,Qingyu Yan RSC Adv., 2013,3, 14960-14962
• 3. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
• 4. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 5. Fe3O4@PANI: a magnetic polyaniline nanomaterial for highly efficient and handy enrichment of intact N-glycopeptides??
  Zhizhen Lai,Mo Zhang,Jinyu Zhou,Tianjing Chen,Dan Li,Xuejing Shen,Jia Liu,Jiang Zhou,Zhili Li Analyst, 2021,146, 4261-4267

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Haloquinolines

Professional Introduction to 6-Fluoroquinoline-8-carbaldehyde (CAS No: 22934-42-5)

6-Fluoroquinoline-8-carbaldehyde, with the chemical identifier CAS No: 22934-42-5, is a fluorinated quinoline derivative that has garnered significant attention in the field of pharmaceutical chemistry and medicinal biology. This compound serves as a versatile intermediate in the synthesis of various pharmacologically active molecules, particularly those targeting infectious diseases and cancer. The presence of a fluorine atom at the 6-position and an aldehyde group at the 8-position imparts unique electronic and steric properties, making it a valuable scaffold for drug design.

The quinoline scaffold itself has a long history in medicinal chemistry, with several well-known drugs derived from this core structure. Notably, fluoroquinolones, such as ciprofloxacin and levofloxacin, are widely used antibiotics that exhibit broad-spectrum activity against Gram-negative and some Gram-positive bacteria. The introduction of fluorine into the quinoline ring enhances metabolic stability, bioavailability, and binding affinity to biological targets. In contrast, the aldehyde functionality provides a reactive site for further chemical modifications, enabling the construction of more complex molecules.

In recent years, 6-Fluoroquinoline-8-carbaldehyde has been explored as a key intermediate in the development of novel antiviral and anticancer agents. The fluorine atom's ability to modulate enzyme interactions has been leveraged in designing inhibitors targeting viral proteases and kinases. For instance, studies have demonstrated its utility in synthesizing compounds that disrupt the replication cycle of RNA viruses by inhibiting critical enzymes such as NS3/4A protease. The aldehyde group has also been utilized in Schiff base formation, leading to metal complexes with potential anticancer properties.

One of the most compelling applications of 6-Fluoroquinoline-8-carbaldehyde is in the realm of oncology. Researchers have identified that quinoline derivatives can selectively target cancer cells by interfering with mitochondrial function and DNA replication. The fluorine atom enhances these effects by improving cell membrane permeability and binding affinity to tumor-specific enzymes. Preclinical studies have shown promising results in animal models, where compounds derived from this scaffold exhibit lower toxicity compared to traditional chemotherapeutic agents while maintaining high efficacy.

The synthesis of 6-Fluoroquinoline-8-carbaldehyde typically involves multi-step organic transformations, starting from commercially available quinoline precursors. Fluorination is often achieved using electrophilic or nucleophilic fluorinating agents, depending on the desired regioselectivity. The introduction of the aldehyde group is commonly accomplished through oxidation reactions or formylation processes. Advances in catalytic methods have further refined these synthetic routes, allowing for higher yields and reduced environmental impact.

The pharmacokinetic profile of derivatives of 6-Fluoroquinoline-8-carbaldehyde is another area of active investigation. Fluorine substitution can significantly influence absorption, distribution, metabolism, and excretion (ADME) properties. For example, fluorinated quinolines often exhibit prolonged half-lives due to enhanced binding to plasma proteins and reduced metabolic clearance. This attribute is particularly advantageous for drugs requiring once-daily dosing regimens.

In conclusion, 6-Fluoroquinoline-8-carbaldehyde (CAS No: 22934-42-5) represents a structurally intriguing compound with broad therapeutic potential. Its unique combination of a fluorinated quinoline core and an aldehyde functional group makes it an indispensable tool for medicinal chemists seeking to develop novel therapeutics against infectious diseases and cancer. As research continues to uncover new applications for this compound, its significance in drug discovery is expected to grow even further.

• 1190321-22-2(5-Fluoro-7-methyl-1H-indole-3-carbaldehyde)
• 1150271-14-9(6-Fluoro-8-methylquinoline)
• 389628-19-7(4-Fluoro-1H-indole-7-carboxaldehyde)
• 2338-71-8(5-fluoro-1H-indole-3-carbaldehyde)
• 2795-41-7(6-fluoro-1H-indole-3-carbaldehyde)
• 603309-90-6(6-Fluoro-1H-indole-7-carbaldehyde)
• 1306605-84-4(6-Fluoroquinoline-8-carboxylic acid)
• 23073-31-6(4-Fluoro-1H-indole-3-carbaldehyde)
• 1346817-49-9(1-(6-Fluoroquinolin-8-yl)ethanone)
• 603306-52-1(5-fluoro-1H-indole-7-carbaldehyde)